Gilead Sciences Inc (NASDAQ:GILD)

61.05
BATS BZX Real-Time Price
As of 2:06pm ET
 -0.06 / -0.10%
Today’s Change
57.04
Today|||52-Week Range
85.97
-6.05%
Year-to-Date
3 Pharma Stocks With Dividends Above 4% to Buy Now
Dec 01 / MotleyFool.com - Paid Partner Content
AstraZeneca's (AZN) sBLA for New Imfinzi Dosage Gets Approval
Nov 24 / Zacks.com - Paid Partner Content
COVID-19 Vaccine Race Heats Up: Drugmarkers on Final Lap
Dec 01 / Zacks.com - Paid Partner Content
Better Buy: Gilead Sciences vs. Pfizer
Nov 23 / MotleyFool.com - Paid Partner Content
Is Gilead Sciences a Great Dividend Stock?
Nov 29 / MotleyFool.com - Paid Partner Content
Could Sorrento Therapeutics Be a Millionaire-Maker Stock?
Nov 22 / MotleyFool.com - Paid Partner Content
Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?
Nov 28 / MotleyFool.com - Paid Partner Content
This Company's New Approach Could Slash Gilead's Profit From HIV Drugs
Nov 22 / MotleyFool.com - Paid Partner Content
Gilead's New CEO Is Going All-In on Acquisitions
Nov 28 / MotleyFool.com - Paid Partner Content
Is There Room for Latecomers to the COVID-19 Party?
Nov 21 / MotleyFool.com - Paid Partner Content
Top 3rd-Quarter Buys of Steven Cohen's Firm
Nov 27 / GuruFocus News - Paid Partner Content
WHO Recommends Against Using Gilead's Remdesivir for COVID-19
Nov 20 / MotleyFool.com - Paid Partner Content
Is This Coronavirus Treatment Setting Investors Up for Failure?
Nov 27 / MotleyFool.com - Paid Partner Content
Gilead (GILD) Down on COVID-19 Drug Remdesivir Update
Nov 20 / Zacks.com - Paid Partner Content
Liquidia (LQDA) PAH Drug Gets FDA's Complete Response Letter
Nov 26 / Zacks.com - Paid Partner Content
Lilly/Incyte's Olumiant Gets FDA Emergency Nod for COVID-19
Nov 20 / Zacks.com - Paid Partner Content
This Biotech Is Up 1,500% This Year. Can It Make You Rich in 2021?
Nov 26 / MotleyFool.com - Paid Partner Content
Is Sorrento Therapeutics Stock a Buy?
Nov 20 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: REGN's Cocktail Gets EUA, GILD & AMGN Provide Updates & More
Nov 25 / Zacks.com - Paid Partner Content
Gilead (GILD) Reports Positive Top-Line Data on HIV Candidate
Nov 19 / Zacks.com - Paid Partner Content
3 High-Yield Stocks at Rock-Bottom Prices
Nov 25 / MotleyFool.com - Paid Partner Content
Sorrento CEO Henry Ji on How the Company Got Its Start
Nov 19 / MotleyFool.com - Paid Partner Content
Regeneron's (REGN) Cocktail Gets EUA for COVID-19 by FDA
Nov 24 / Zacks.com - Paid Partner Content
Should Value Investors Choose Gilead Sciences (GILD) Stock?
Nov 19 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer
Nov 24 / Zacks.com - Paid Partner Content
What Awaits Pharma Giants in Last Lap of COVID-19 Vaccine Race?
Nov 19 / Zacks.com - Paid Partner Content
Lilly's (LLY) Coronavirus Treatment Gets Interim Nod in Canada
Nov 24 / Zacks.com - Paid Partner Content
The vaccine news is great for most stocks -- unless you're Zoom
Nov 09 / CNN.com - Paid Partner Content